Prostate Cancer
📧 Sign up to get email alerts when something new happens for Prostate Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-03-18Clinical Trial Update: Mannitol Versus Nitroglycerin for Kidney Injury Prevention in Robotic-assisted Radical Prostatectomy or Cystectomy [NA]
A clinical trial comparing mannitol versus nitroglycerin to prevent acute kidney injury during robotic-assisted radical prostatectomy or cys…
-
CLINICAL_TRIALS research · 2026-03-18Clinical Trial Update: Predictors of Mental Health in Men With Prostate Cancer Undergoing a Patient Empowerment Program [NA]
This clinical trial update describes predictors of mental health in men with prostate cancer undergoing a patient empowerment program; the s…
-
CLINICAL_TRIALS research · 2026-03-18Clinical Trial Update: A Phase II Clinical Two-Stage Study of Transcranial Magnetic Stimulation in Preventing Postoperative Delirium in Elderly Patients After Urological Surgery [NA]
This registry entry notes a Phase II two-stage trial evaluating transcranial magnetic stimulation to prevent postoperative delirium in elder…
-
CLINICAL_TRIALS research · 2026-03-18Clinical Trial Update: Lung US for PEEP Optimization in Robotic Radical Prostatectomy or Cystectomy Patients [NA]
This document provides an update on a clinical trial sponsored by Nazmy Edward Seif evaluating lung ultrasound for optimizing PEEP during ro…
-
CLINICAL_TRIALS research · 2026-03-18Clinical Trial Update: Access to Genetic Testing in Underserved Patients With Cancer [NA]
This entry reports on a clinical trial investigating access to genetic testing for cancer patients in underserved populations, with recruitm…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-03-17Clinical Trial Update: Darolutamide ± ADT as Neoadjuvant Therapy in High-Risk/Very High-Risk Localized Prostate Cancer [Phase 2]
A Phase 2 trial evaluating darolutamide with or without androgen deprivation therapy as neoadjuvant treatment before definitive therapy in h…
-
CLINICAL_TRIALS research · 2026-03-17Clinical Trial Update: Early Phase Study of KESONOTIDE™in Participants With Solid Tumours [Phase 1, Phase 2]
KESONOTIDE is being studied in an early-phase (Phase 1/Phase 2) trial for solid tumours and is currently recruiting across multiple cancer i…
-
CLINICAL_TRIALS research · 2026-03-17Clinical Trial Update: INSIGHT-PCa: MRI- and PHI-Guided Risk-Adapted Strategy for Prostate Cancer Diagnosis [NA]
A clinical trial to test an MRI- and PHI-guided risk-adapted diagnostic strategy for detecting prostate cancer; recruitment is ongoing.
-
CLINICAL_TRIALS research · 2026-03-17Clinical Trial Update: SpaceOAR Post-Market Registry Study
A post-market SpaceOAR registry study is currently recruiting at Sheffield Teaching Hospitals NHS Foundation Trust to collect data on its us…
-
CLINICAL_TRIALS research · 2026-03-17Clinical Trial Update: PET Imaging Study of 89Zr-DFO-YS5 in Men With Prostate Cancer [Phase 1]
Phase 1 PET imaging study evaluating 89Zr-DFO-YS5 in men with prostate cancer, including metastatic castration-resistant disease; the trial …
-
CLINICAL_TRIALS research · 2026-03-17Clinical Trial Update: 64Cu-GRIP B in Patients With Advanced Malignancies [Phase 1, Phase 2]
Clinical trial update for a Phase 1/Phase 2 study of 64Cu-GRIP B in advanced malignancies, including prostate and renal cancers, which is cu…
-
CLINICAL_TRIALS research · 2026-03-17Clinical Trial Update: Radiotherapy After Prostatectomy for Node Positive Prostate Cancer [Phase 3]
Phase 3 trial evaluating image-guided radiotherapy after prostatectomy for node-positive prostate cancer; the study is currently active but …
-
CLINICAL_TRIALS research · 2026-03-16Clinical Trial Update: Two-fraction Proton Therapy With MRI Guidance for Prostate Cancer: A Phase II Trial [NA]
This clinical trial update describes a Phase II study evaluating two-fraction proton therapy with MRI guidance for prostate cancer, currentl…
-
CLINICAL_TRIALS research · 2026-03-16Clinical Trial Update: Prostate Risk Or Radiology Assessment Non-inferiority Design, Upfront MRI or Risk Calculator in Men With Suspected Prostate Cancer [NA]
This clinical trial compares upfront MRI to a prostate cancer risk calculator in men with suspected disease using a non-inferiority design. …
-
CLINICAL_TRIALS research · 2026-03-16Clinical Trial Update: Engage Psychosocial Intervention for Cancer Symptoms [NA]
Duke University is recruiting for a clinical trial to evaluate an engage psychosocial intervention to help manage cancer-related symptoms ac…
-
CLINICAL_TRIALS research · 2026-03-16Clinical Trial Update: Study of Sipuleucel-T With or Without Continuing New Hormonal Agents in Metastatic Prostate Cancer [Phase 2]
A Phase 2 clinical trial is evaluating sipuleucel-T with or without continuing new hormonal agents in metastatic prostate cancer, and recrui…
-
CLINICAL_TRIALS research · 2026-03-16Clinical Trial Update: Feasibility Study of Urinary cfDNA Analysis as a Non-invasive Monitoring Tool in Patients With Prostate or Bladder Cancer
Feasibility study evaluating urinary cell-free DNA as a non-invasive monitoring tool in prostate cancer and bladder cancer.
-
CLINICAL_TRIALS research · 2026-03-16Clinical Trial Update: Apalutamide, Abiraterone Acetate, and Prednisone in Treating Participants With Metastatic Castration Resistant Prostate Cancer [Phase 2]
A Phase 2 trial evaluating a combination of apalutamide, abiraterone acetate, and prednisone in metastatic castration-resistant prostate can…
-
CLINICAL_TRIALS research · 2026-03-16Clinical Trial Update: Prospective Clinical Study Comparing PROMS After Adaptive or Conventional Radiotherapy in Prostate Cancer [NA]
A prospective clinical study comparing patient-reported outcomes after adaptive radiotherapy versus conventional radiotherapy in prostate ca…
-
CLINICAL_TRIALS research · 2026-03-16Clinical Trial Update: A Study to Evaluate Hypofractionated Proton Therapy or IMRT for Recurrent, Oligometastatic Prostate Cancer [Phase 2]
This Phase 2 trial compares hypofractionated proton therapy to IMRT for recurrent, oligometastatic prostate cancer and is currently active b…
-
CLINICAL_TRIALS research · 2026-03-16Clinical Trial Update: Radium-223 in Biochemically Recurrent Prostate Cancer [Phase 2]
A Phase 2 clinical trial evaluating Radium-223 for biochemically recurrent prostate cancer is active but not recruiting.
-
CLINICAL_TRIALS research · 2026-03-16Clinical Trial Update: A Multicenter, Prospective Study on the Prognostic Value of PSMA PET in Patients With Newly Diagnosed, Treatment-naïve Prostate Cancer
A multicenter prospective study is evaluating the prognostic value of PSMA PET imaging in patients with newly diagnosed, treatment-naïve pro…
-
CLINICAL_TRIALS research · 2026-03-13Clinical Trial Update: Study of Recurrence-directed Therapy (RDT) With or Without Androgen-Deprivation Therapy (ADT) In Patients With Radio-recurrent Oligo-metastatic Hormone/Castrate Sensitive Prostate Cancer (romCSPC) [Phase 2]
Phase 2 clinical trial evaluating recurrence-directed therapy with or without androgen-deprivation therapy in patients with radio-recurrent …
-
CLINICAL_TRIALS research · 2026-03-13Clinical Trial Update: Germline DNA-Based Radiosensitivity Biomarker Influence on Toxicity Following Prostate Radiotherapy, GARUDA Trial [NA]
The GARUDA trial update describes ongoing research on how germline DNA-based radiosensitivity biomarkers may influence toxicity from prostat…
-
CLINICAL_TRIALS research · 2026-03-13Clinical Trial Update: Abiraterone and Prednisone or Darolutamide for the Treatment of Advanced Prostate Cancer [Phase 2]
This is a Phase 2 clinical trial evaluating Abiraterone with prednisone or Darolutamide for advanced prostate cancer; the study is currently…